TYW1 Inhibitors
TYW1 inhibitors belong to a specialized class of chemical agents that target the TYW1 enzyme, a crucial component in the biosynthetic pathway of wybutosine-like molecules. TYW1, or tRNA-yW synthesizing protein 1, is an enzyme that plays a pivotal role in the post-transcriptional modification of certain nucleosides in the phenylalanine tRNA of eukaryotic organisms. This specific modification involves the intricate process of adding a yW base to the tRNA molecule, which is essential for the proper functioning and stabilization of tRNA in protein synthesis. The wybutosine modification is particularly significant because it contributes to the fidelity of codon-anticodon pairing during the translation process, ensuring that proteins are synthesized correctly. Inhibitors of TYW1 are designed to specifically interact with this enzyme, effectively hindering its catalytic action. The inhibition of TYW1 disrupts the wybutosine synthesis pathway, which can have profound effects on the molecular biology of the cell due to the importance of this modification in genetic translation mechanisms.
Chemically, TYW1 inhibitors are diverse, with varying structures tailored to interact with the active site or allosteric sites of the TYW1 enzyme. The design of these inhibitors often involves a deep understanding of the enzyme's structure and the key residues that are involved in the catalytic process. Inhibitors may mimic the substrate or intermediate states of the enzymatic reaction, thus competing with the natural substrates or binding irreversibly to the active site. Others may bind to regions of the enzyme that are essential for its conformational stability or its interaction with other molecular partners, thereby indirectly reducing its activity. The development and study of TYW1 inhibitors are grounded in a variety of chemical disciplines, including organic chemistry, biochemistry, and medicinal chemistry, utilizing techniques such as high-throughput screening, computational docking models, and structure-activity relationship (SAR) analysis. These efforts contribute to a deeper understanding of the enzyme's function and the potential regulation of its activity by small molecules. Notwithstanding their specific mechanism of action, the exploration of TYW1 inhibitors is a testament to the intricate interplay between chemical agents and biological systems.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $36.00 $88.00 $220.00 $436.00 | 8 | |
Mimosine inhibits the activity of tRNA synthetases, which are essential for protein synthesis. TYW1's enzymatic function is related to tRNA modification; thus, inhibiting tRNA synthetase indirectly reduces the substrate availability for TYW1. | ||||||
Deferoxamine | 70-51-9 | sc-507390 | 5 mg | $255.00 | ||
Deferoxamine chelates iron, which is a cofactor necessary for many enzymes. Since TYW1 is an iron-sulfur cluster enzyme, its activity is likely dependent on iron availability, and chelation of iron by deferoxamine could reduce TYW1's enzymatic activity. | ||||||
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
Methimazole is a thiourea derivative that can potentially inhibit the function of iron-sulfur cluster enzymes by thiol group interaction. This action might indirectly lead to a reduction in TYW1 activity by affecting its iron-sulfur cluster. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Cerulenin specifically inhibits fatty acid synthase (FAS). Since TYW1 is involved in the modification of tRNAs that are ultimately required for the synthesis of proteins, including enzymes like FAS, its inhibition can indirectly reduce TYW1 activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in protein elongation. As TYW1 is involved in tRNA modification, which is crucial for protein synthesis, cycloheximide indirectly reduces TYW1-mediated processes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is a uracil analog that disrupts pyrimidine metabolism. This can lead to an imbalance in the nucleotide pool, potentially altering tRNA modification processes where TYW1 is involved, and thereby, reducing its functional activity. | ||||||
Azaserine | 115-02-6 | sc-29063 sc-29063A | 50 mg 250 mg | $312.00 $924.00 | 15 | |
Azaserine is a glutamine antagonist that inhibits amidotransferases. By interfering with glutamine metabolism, it can affect the biosynthesis of nucleotides and subsequent tRNA modification, potentially reducing TYW1 activity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea is a ribonucleotide reductase inhibitor, leading to decreased DNA synthesis. This indirectly affects RNA and protein synthesis, and since TYW1 is involved in tRNA modification, its activity could be indirectly reduced. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds DNA at the transcription initiation complex and prevents elongation of RNA chains by RNA polymerase. This action leads to reduced RNA synthesis, indirectly affecting TYW1's role in tRNA modification. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II and III, which can lead to a decrease in RNA synthesis, including tRNA. TYW1's function is closely tied to tRNA modification, so inhibition of RNA polymerase indirectly decreases TYW1 activity. | ||||||